Neurocrine launches CAH community website ahead of FDA filing
https://seekingalpha.com/news/4093768-neurocrine-launches-cah-community-website-ahead-of-fda-filing?source=feed_sector_healthcare
Apr 24, 2024 - Neurocrine (NBIX), which has developed a drug for congenital adrenal hyperplasia, has launched a new interactive website to support patients with the condition. Read more here.
0
Zacks.com featured highlights Cboe Global Markets, Cardinal Health, Assurant, Installed Building Products and FedEx
https://www.zacks.com/stock/news/2192711/zacks-com-featured-highlights-cboe-global-markets-cardinal-health-assurant-installed-building-products-and-fedex?cid=CS-ZC-FT-press_releases-2192711
Dec 04, 2023 - Cboe Global Markets, Cardinal Health, Assurant, Installed Building Products and FedEx have been highlighted in this Screen of The Week article.
0
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2194781/why-cardinal-health-cah-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2194781
Dec 07, 2023 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Reasons to Add Cardinal Health (CAH) to Your Portfolio Now
https://www.zacks.com/stock/news/2196582/reasons-to-add-cardinal-health-cah-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2196582
Dec 12, 2023 - Cardinal Health (CAH) continues to gain traction from a solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
0
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
https://www.zacks.com/stock/news/2196784/are-medical-stocks-lagging-cardinal-health-cah-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2196784
Dec 12, 2023 - Here is how Cardinal Health (CAH) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
0
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
https://www.zacks.com/stock/news/2197284/cardinal-health-inc-cah-hit-a-52-week-high-can-the-run-continue?cid=CS-ZC-FT-52_week_high-2197284
Dec 13, 2023 - Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
0
5 Impressive MedTech Industry Growth Stocks to Buy for 2024
https://www.zacks.com/stock/news/2203633/5-impressive-medtech-industry-growth-stocks-to-buy-for-2024?cid=CS-ZC-FT-analyst_blog|investment_ideas-2203633
Dec 29, 2023 - Stocks such as HAE, PEN, EXAS, PODD and CAH are set to garner remarkable growth for investors.
0
5 Low-Leverage Stocks to Buy Amid Mixed Investor Sentiments
https://www.zacks.com/stock/news/2206785/5-low-leverage-stocks-to-buy-amid-mixed-investor-sentiments?cid=CS-ZC-FT-analyst_blog|rw-2206785
Jan 08, 2024 - The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy LOB, MAR, CAH, FN and WING.
0
Cardinal Health (CAH) Streamlines Operation With New Structure
https://www.zacks.com/stock/news/2208203/cardinal-health-cah-streamlines-operation-with-new-structure?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2208203
Jan 10, 2024 - Cardinal Health's (CAH) new reporting structure is likely to streamline operations, providing better visibility of growth areas. At-home solutions and OptiFreight Logistics are possibly the key value creators.
0
3 Top-Ranked Large-Caps to Buy for Growth
https://www.zacks.com/stock/news/2209733/3-top-ranked-large-caps-to-buy-for-growth?cid=CS-ZC-FT-video_blog-2209733
Jan 12, 2024 - Large-caps provide many meaningful advantages, including a less volatile approach, dividend payouts, and greater analyst coverage.
0
Page 1>